Do CCR5 (CCR5Δ32) and TLR3 (RS5743313) gene polymorphisms prevent chronic hepatitis B infection?. Issue 1 (15th December 2022)

• Record Type: Journal Article
• Authors: Tuncel, Burçin; Kaygusuz, Sedat; Sayın Kocakap, Derya Beyza; Aksoy, Emel; Azkur, Ahmet Kürşat
• Is Part Of: Journal of medical virology. Volume 95:Issue 1(2023)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-12-15
• Subjects: evolution -- genetic variability -- hepatitis B virus -- immune system -- pathogenesis -- virus classification; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.28376
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract: Hepatitis B virus (HBV) is still a significant health problem in human. HBV severity or sensitivity of patients may be based on the individual genetic factors significantly. The aim of this study is to investigate the association of CCR5 (CCR5Δ32), TLR3 (rs5743313) functional gene polymorphisms, interferon‐gamma (IFN‐ɣ) level in HBV infection, which are thought to play an important role in innate and acquired immunity in patients who have undergone HBV seroconversion and those who have chronic hepatitis B disease and receive treatment. One hundred patients who are became naturally immune against HBV infection (HBsAg negative, anti‐HBc IgG, and anti‐HBs IgG positive), and 100 patients with chronic hepatitis B infection (>6 months HBsAg positive) who are receiving oral antiviral therapy were compared for CCR5Δ32, TLR3 (rs5743313) genotypes and serum IFN‐ɣ level. It was found that CCR5Δ32 polymorphism (Wt/Δ32 and Δ32/Δ32) was significantly higher in the chronic hepatitis B group ( p = 0.048) but not for TLR3 gene polymorphism. However, serum IFN‐ɣ level was significantly higher in the HBV seroconversion group (75 ± 89 ng/ml) than in the chronic hepatitis B group (4.35 ± 17.27 ng/ml) ( p < 0.001). In conclusion, a higher CCR5Δ32 allele frequency in patients with chronic hepatitis B might be considered as a marker of progression to chronic hepatitis.